Asia Pacific In Vitro Diagnostics Quality Control Market Size & Outlook

The in vitro diagnostics quality control market in Asia Pacific is expected to reach a projected revenue of US$ 320.5 million by 2030. A compound annual growth rate of 3.8% is expected of Asia Pacific in vitro diagnostics quality control market from 2024 to 2030.
Revenue, 2023 (US$M)
$247.0
Forecast, 2030 (US$M)
$320.5
CAGR, 2024 - 2030
3.8%
Report Coverage
Asia Pacific

Asia Pacific in vitro diagnostics quality control market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific in vitro diagnostics quality control market highlights

  • The Asia Pacific in vitro diagnostics quality control market generated a revenue of USD 247.0 million in 2023.
  • The market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
  • In terms of segment, controls was the largest revenue generating product in 2023.
  • Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 247.0 million
Market revenue in 2030USD 320.5 million
Growth rate3.8% (CAGR from 2023 to 2030)
Largest segmentControls
Fastest growing segmentCalibrators
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationControls, Calibrators
Key market players worldwideSiemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 19.3% of the global in vitro diagnostics quality control market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 320.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Diagnostics Quality Control Market Scope

In vitro diagnostics quality control market segmentation & scope
Total Protein
Albumin
Blood Urea Nitrogen
Uric Acid
Creatinine
Sodium
Potassium
Chloride
Calcium
Magnesium
Inorganic Phosphorus
Aspartate Transaminase
Creatine Kinase
Gamma Glutamyl transferase
Total Bilirubin
Glucose
Iron
Alanine Transaminase
Alkaline Phosphatase
Alpha Amylase
Total Cholesterol
Triglyceride
Lactate Dehydrogenase
Immunoglobulin G
Immunoglobulin A
Immunoglobulin M
Complement 3
Complement 4
C-Reactive Protein
Rheumatoid Factor
Anti-Streptolysin -O
Beta 2 Micorgloblin
Cystatin-C
Myoglobin
Troponin T and I
Others
Calibrators
Others
Plasma-based Control
Serum-based Control
Whole blood-based Control
Others
Quality Assurance Services
Data Management Solutions
Immunochemistry
Hematology
Alkaline Phosphatase (ALP)
Alanine Transaminase (ALT)
Aspartate Transaminase (AST)
Creatine Kinase MB (CK-MB)
Albumin
Creatinine
Glucose
Triglycerides
Amylase
Others
Molecular Diagnostics
Coagulation
Microbiology
Others
Independent Controls
Instrument Specific Controls
OEM Controls
Hospitals
Laboratories
Home Care
Others

In Vitro Diagnostics Quality Control Market Companies

Name Profile # Employees HQ Website

Asia Pacific in vitro diagnostics quality control market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.


Controls was the largest segment with a revenue share of 48.34% in 2023. Horizon Databook has segmented the Asia Pacific in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.


Asia Pacific portrays a high potential for this market majorly due to the increasing number of companies getting involved in the manufacturing of IVDs and IVD quality control products. Moreover, a rise in awareness for early and precise diagnosis fosters the demand for IVDs. 

For instance, the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine (APFCB) is engaged in promoting awareness about the use of IVDs through several committees. Moreover, regulatory authorities at a country level.

The Pharmaceuticals and Medical Devices Evaluation Agency (PMDA), the National Medical Products Administration (NMPA), the Central Drugs Standard Control Organization (CDSCO), and others, are undertaking favorable initiatives to increase the market penetration of IVD and IVD quality control products. 


Reasons to subscribe to Asia Pacific in vitro diagnostics quality control market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific in vitro diagnostics quality control market databook

  • Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific in vitro diagnostics quality control market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific in vitro diagnostics quality control market size, by country, 2018-2030 (US$M)

Asia Pacific In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific in vitro diagnostics quality control market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more